<code id='B898F0E246'></code><style id='B898F0E246'></style>

<acronym id='B898F0E246'></acronym>

<center id='B898F0E246'><center id='B898F0E246'><tfoot id='B898F0E246'></tfoot></center><abbr id='B898F0E246'><dir id='B898F0E246'><tfoot id='B898F0E246'></tfoot><noframes id='B898F0E246'>

<optgroup id='B898F0E246'><strike id='B898F0E246'><sup id='B898F0E246'></sup></strike><code id='B898F0E246'></code></optgroup>

<b id='B898F0E246'><label id='B898F0E246'><select id='B898F0E246'><dt id='B898F0E246'><span id='B898F0E246'></span></dt></select></label></b><u id='B898F0E246'></u>

~~<i id='B898F0E246'><strike id='B898F0E246'><tt id='B898F0E246'><pre id='B898F0E246'></pre></tt></strike></i>~~

Home» explore» explore

explore

explore

author：fashion 2025-09-29 21:36:47 Page View：26

Rachel Haurwitz of Caribou Biosciences — Rachel Haurwitz, CEO of Caribou Biosciences. Elizabeth D. Herman for STAT

Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies.

In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

advertisement

The CB-010 result is still preliminary, but it begins to compare favorably to currently approved CAR-T therapies, which must be custom made for each patient and have shown durable remission rates in the range of 36-40%, said Caribou CEO Rachel Haurwitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Lupron, used to halt puberty in children, may cause lasting health problems
Next article： Wildfire smoke exposes gaps in outdoor worker protections

focus

In age of alternative facts, a scholarly course on calling out crap

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Following judge's order, DOJ releases slightly less

Following judge's order, DOJ releases slightly less

3:32ApolicecarisseenoutsideformerUSPresidentDonaldTrump'sresidenceinMar-A-Lago,Fla.onAug.8,2022.Gior

23andMe had bad news about my health. I wish a person had delivered it

23andMe had bad news about my health. I wish a person had delivered it

ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

JohnLocher/APPresidentTrump’srevelationthisweekthathe’stakinghydroxychloroquinetowardoffCovid-19sent

read more